Hikari Power’s Novo Nordisk NVO Stock Holding History

Hikari Power’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.79M	Hold	130,300	–	–	0.42%	23
2025 Q4	$6.63M	Hold	130,300	–	–	0.52%	25
2025 Q3	$7.23M	Hold	130,300	–	–	0.58%	25
2025 Q2	$8.99M	Hold	130,300	–	–	0.75%	21
2025 Q1	$9.05M	Hold	130,300	–	–	0.72%	21
2024 Q4	$11.2M	Hold	130,300	–	–	0.97%	17
2024 Q3	$15.5M	Hold	130,300	–	–	1.29%	16
2024 Q2	$18.6M	Hold	130,300	–	–	1.68%	14
2024 Q1	$16.7M	Sell	130,300 -15,750	-11%	-$1.87M	1.44%	15
2023 Q4	$15.1M	Sell	146,050 -22,350	-13%	-$2.21M	1.44%	16
2023 Q3	$15.3M	Sell	168,400 -21,400	-11%	-$1.89M	1.5%	14
2023 Q2	$15.4M	Sell	189,800 -44,000	-19%	-$3.59M	1.48%	17
2023 Q1	$18.6M	Hold	233,800	–	–	1.87%	13
2022 Q4	$15.8M	Hold	233,800	–	–	1.55%	17
2022 Q3	$11.6M	Hold	233,800	–	–	1.3%	20
2022 Q2	$13M	Hold	233,800	–	–	1.4%	20
2022 Q1	$13M	Hold	233,800	–	–	1.17%	21
2021 Q4	$13.1M	Hold	233,800	–	–	1.22%	21
2021 Q3	$11.2M	Hold	233,800	–	–	1.13%	21
2021 Q2	$9.79M	Hold	233,800	–	–	0.97%	23
2021 Q1	$7.88M	Hold	233,800	–	–	0.83%	25
2020 Q4	$8.16M	Hold	233,800	–	–	0.91%	24
2020 Q3	$8.12M	Hold	233,800	–	–	1.03%	22
2020 Q2	$7.66M	Hold	233,800	–	–	1.05%	23
2020 Q1	$7.04M	Hold	233,800	–	–	0.99%	26
2019 Q4	$6.77M	Sell	233,800 -191,780	-45%	-$5.31M	0.7%	34
2019 Q3	$11M	Hold	425,580	–	–	1.19%	19
2019 Q2	$10.9M	Sell	425,580 -71,000	-14%	-$1.75M	1.17%	23
2019 Q1	$13M	Sell	496,580 -181,500	-27%	-$4.46M	1.36%	22
2018 Q4	$15.6M	Hold	678,080	–	–	1.76%	16
2018 Q3	$16M	Hold	678,080	–	–	1.62%	18
2018 Q2	$15.6M	Sell	678,080 -169,520	-20%	-$4.03M	1.72%	17
2018 Q1	$20.9M	Hold	847,600	–	–	2.46%	11
2017 Q4	$22.7M	Hold	847,600	–	–	2.69%	9
2017 Q3	$20.4M	Hold	847,600	–	–	2.64%	8
2017 Q2	$18.2M	Hold	847,600	–	–	2.45%	10
2017 Q1	$14.5M	Buy	847,600 +25,200	+3%	+$439K	2.07%	13
2016 Q4	$14.7M	Sell	822,400 -146,200	-15%	-$2.65M	2.1%	12
2016 Q3	$20.1M	Buy	968,600 +84,600	+10%	+$2.1M	2.39%	9
2016 Q2	$23.8M	Hold	884,000	–	–	2.74%	6
2016 Q1	$24M	Hold	884,000	–	–	2.75%	8
2015 Q4	$25.7M	Hold	884,000	–	–	3.5%	6
2015 Q3	$24M	Sell	884,000 -127,600	-13%	-$3.61M	3.99%	5
2015 Q2	$27.7M	Sell	1,011,600 -100,400	-9%	-$2.82M	4.13%	6
2015 Q1	$29.7M	Hold	1,112,000	–	–	4.21%	6
2014 Q4	$23.6M	Hold	1,112,000	–	–	3.3%	8
2014 Q3	$26.5M	Hold	1,112,000	–	–	3.92%	7
2014 Q2	$25.7M	Buy	1,112,000 +64,600	+6%	+$1.43M	3.71%	8
2014 Q1	$23.9K	Buy	+1,047,400	New	+$22.3M	2.91%	8

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hikari Power's NVO Position: Q1 2026 in Review

Hikari Power held its Novo Nordisk (NVO) position steady in Q1 2026 at 130,300 shares worth $4.79M. The position accounts for 0.42% of the portfolio, ranked #23.

Hikari Power first reported a position in NVO in Q1 2014 and has held it in 49 quarters since. The position peaked at $29.7M in Q1 2015. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Hikari Power held 130,300 shares of Novo Nordisk worth $4.79M as of Q1 2026.
Hikari Power left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up 0.42% of Hikari Power's portfolio in Q1 2026, its #23 holding.
Hikari Power first reported a position in Novo Nordisk in Q1 2014 and has held it in 49 quarters since.
Hikari Power's Novo Nordisk position peaked at $29.7M in Q1 2015.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hikari Power's 13F filing for Q1 2026, filed 30 Apr 2026.